Jean-Pierre Bouiller
Mitglied des Investmentausschusses bei Sofimac Régions SAS
Aktive Positionen von Jean-Pierre Bouiller
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Sofimac Régions SAS
 Sofimac Régions SAS Investment ManagersFinance Sofimac Régions SAS is a Private Equity/Venture Capital firm, a subsidiary of Sofimac Investment Managers SAS founded in 1978. Sofimac Régions is headquartered in Clermont-Ferrand. | Mitglied des Investmentausschusses | 22.06.2010 | - |
| Private Equity Investor | 01.10.1999 | - |
Karriereverlauf von Jean-Pierre Bouiller
Ehemalige bekannte Positionen von Jean-Pierre Bouiller
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Imaxio SA
 Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Direktor/Vorstandsmitglied | 18.01.2011 | - |
Statistik
International
| Frankreich | 3 |
Operativ
| Investment Committee Member | 1 |
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
Sektoral
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Sofimac Régions SAS
Sofimac Régions SAS Investment ManagersFinance Sofimac Régions SAS is a Private Equity/Venture Capital firm, a subsidiary of Sofimac Investment Managers SAS founded in 1978. Sofimac Régions is headquartered in Clermont-Ferrand. | Finance |
Imaxio SA
Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Health Technology |
- Börse
- Insiders
- Jean-Pierre Bouiller
- Erfahrung
